News dynamics
China International Medical Equipment (Spring) Expo

China International Medical Equipment (Spring) Expo

Event Dates: April 8-11, 2025 Event City: Shanghai Venue: Shanghai National Exhibition and Convention Center

08

2025

/

04

Participate in the China (Shenzhen) International Medical Equipment Exhibition CMEF from October 12th to October 15th, 2024

Participate in the China (Shenzhen) International Medical Equipment Exhibition CMEF from October 12th to October 15th, 2024

Participate in the China (Shenzhen) International Medical Equipment Exhibition CMEF from October 12th to October 15th, 2024

12

2024

/

10

Announcement of the State Food and Drug Administration on Protected Varieties of Traditional Chinese Medicines (No. 13 Extension of Protection Period) (No. 152 of 2023)

Announcement of the State Food and Drug Administration on Protected Varieties of Traditional Chinese Medicines (No. 13 Extension of Protection Period) (No. 152 of 2023)

According to Article 16 of the Regulations on the Protection of Traditional Chinese Medicine Varieties and relevant provisions, the State Food and Drug Administration has approved the review organized by the National Committee for the Protection and Review of Traditional Chinese Medicine Varieties:

12

2023

/

12

The 27th Annual Meeting of the Global Coordination Committee on Medical Device Regulations Held in Shanghai

The 27th Annual Meeting of the Global Coordination Committee on Medical Device Regulations Held in Shanghai

From November 27 to 30, the 27th Global Medical Device Regulation Coordination (GHWP) Annual Meeting and Technical Committee Meeting was held in Shanghai. Li Li, Secretary of the Party Leadership Group and Director of the State Food and Drug Administration, attended the annual meeting and delivered a speech.

12

2023

/

12

Announcement of the State Food and Drug Administration on Issues concerning Encouraging Innovation and Standardizing Management of New Raw Materials for Cosmetics (No. 143 of 2023)

Announcement of the State Food and Drug Administration on Issues concerning Encouraging Innovation and Standardizing Management of New Raw Materials for Cosmetics (No. 143 of 2023)

In order to encourage and support the research and innovation of new cosmetic raw materials, standardize the research, development, use, registration and filing management of new raw materials, ensure the quality and safety of raw materials and products, protect the health of consumers, and promote the healthy development of the cosmetics industry, in accordance with the Regulations on the Supervision and Administration of Cosmetics (hereinafter referred to as the Regulations), the Measures for the Administration of Cosmetics Registration and Filing (hereinafter referred to as the Measures) and other regulations, the relevant matters concerning strengthening the management of new raw materials for cosmetics are hereby announced as follows:

12

2023

/

12

Notice of the General Department of the State Food and Drug Administration on Issuing the Guidelines for Entrusted Production Site Inspection by Drug Marketing Authorization Holders

Notice of the General Department of the State Food and Drug Administration on Issuing the Guidelines for Entrusted Production Site Inspection by Drug Marketing Authorization Holders

In order to strengthen the supervision and management of the production entrusted by the holders of drug marketing license, the State Food and Drug Administration has organized and formulated the guidelines for on-site inspection of production entrusted by drug marketing license holders, which are hereby issued and shall be implemented as of the date of promulgation.

12

2023

/

12

Notice of the General Department of the State Food and Drug Administration on Early Termination of the Protection of Traditional Chinese Medicine Varieties

Notice of the General Department of the State Food and Drug Administration on Early Termination of the Protection of Traditional Chinese Medicine Varieties

According to the "Regulations on the Protection of Traditional Chinese Medicine Varieties" and the former State Food and Drug Administration's "Notice on Printing and Distributing the Guiding Principles for the Protection of Traditional Chinese Medicine Varieties" (State Food and Drug Administration Note [2009] No. 57), the State Food and Drug Administration agreed to the National Traditional Chinese Medicine Varieties The opinions of the Protection Review Committee have terminated the protection of breviscapine dropping pills in advance. The relevant matters are hereby notified as follows:

12

2023

/

12

Announcement of the State Food and Drug Administration on Re-registration Management of Chemical Raw Materials and Other Relevant Matters (No. 129 of 2023)

Announcement of the State Food and Drug Administration on Re-registration Management of Chemical Raw Materials and Other Relevant Matters (No. 129 of 2023)

In order to further implement the relevant requirements of the Drug Administration Law, the regulations for the implementation of the Drug Administration Law, and the measures for the Administration of Drug Registration on the management of chemical raw materials, we hereby further clarify the issuance of approval notices for chemical raw materials and the management of re-registration. The announcement is as follows:

12

2023

/

12

< 12 >

©ZHEJIANG HONGHENG MEDICAL TECHNOLOGY CO., LTD

Powered by www.300.cn SEO

Business License